13F filer · CIK 19617 ↗
Jpmorgan Chase & Co
You are looking at Q3 2019. See the latest, Q2 2026 →
Reported value
$502.15B
−1.8% on the quarter before
Positions
5,794
456 new · 498 sold out
Top 10
15.6%
of the value
Est. gain
+$4.25B
on stocks held all quarter
Est. return
+1.0%
on those stocks since Q2 2019
Positions as of Sep 30, 2019, from Jpmorgan Chase & Co's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 25% of the reported value, each sized by its share, colored by what the fund did with it since Q2 2019. Striped tiles are options.
Largest buys
Since Q2 2019, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Ishares 7-10 Year Treasury B~$2.03BAdded · 0.4% → 0.8%+18,058,241 shares
- Vanguard Total Intl Bond ETF~$1.94BAdded · 0.8% → 1.3%+33,001,163 shares
- Ishares 3-7 Year Treasury Bo~$1.28BAdded · 0.0% → 0.3%+10,089,124 shares
- Ishares 20 Year Treasury Bo~$935.6MAdded · 0.0% → 0.2%+6,538,650 shares
- Ishares Russell 2000 ETF~$912.0MAdded · 0.2% → 0.4%+6,025,864 shares
- Edison Intl~$817.1MAdded · 0.1% → 0.3%+10,833,393 shares
- Abbvie Inc~$694.7MAdded · 0.1% → 0.2%+9,175,219 shares
- United Technologies Corp~$576.3MAdded · 0.2% → 0.3%+4,220,995 shares
- Bristol Myers Squibb Co~$543.4MAdded · 0.2% → 0.4%+10,715,158 shares
- Ishares TrCALL~$509.7MAdded · 0.1% → 0.2%+12,465,200 underlying
Largest sells
Since Q2 2019, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- SPDR S&P 500 ETF TrPUT~$3.29BCut · 1.5% → 0.9%−11,079,400 underlying
- SPDR S&P 500 ETF Trust~$3.07BCut · 5.0% → 4.5%−10,350,727 shares
- Ishares Short Treasury Bond~$2.61BCut · 0.8% → 0.3%−23,593,375 shares
- Ishares Core U.S. Aggregate~$1.48BCut · 0.6% → 0.3%−13,112,171 shares
- Vanguard Short-Term Bond ETF~$1.26BCut · 0.3% → 0.0%−15,615,306 shares
- Ishares Iboxx Investment Gra~$1.00BCut · 0.2% → 0.1%−7,857,673 shares
- Blackstone Group L P~$984.6MSold out · 0.2% → 0.0%−22,219,781 shares
- Texas Instruments~$911.1MCut · 0.7% → 0.6%−7,049,826 shares
- Visa Inc.~$902.8MCut · 0.5% → 0.3%−5,248,819 shares
- Pfizer Inc~$712.8MCut · 0.9% → 0.6%−19,838,497 shares
Holdings
As of Sep 30, 2019. Changes are in shares against Jun 30, 2019, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SPDR S&P 500 ETF TrustFUND · shares −12% · price +1.8% | 4.5% | $22.82B | +$405.2M | ||||||||
| MicrosoftCOMMON · shares −5.1% · price +3.6% | 2.5% | $12.52B | +$439.6M | ||||||||
| AmazonCOMMON · shares −6.1% · price −8.8% | 1.4% | $7.03B | −$681.9M | ||||||||
| AppleCOMMON · shares −2.1% · price +12.1% | 1.4% | $6.99B | +$756.0M | ||||||||
| Vanguard Total Intl Bond ETFFUND · shares +44% · price +2.8% | 1.3% | $6.34B | +$118.1M | ||||||||
| Ishares Msci Eafe ETFFUND · shares −4.5% · price −0.2% | 1.1% | $5.37B | −$12.4M | ||||||||
| SPDR S&P 500 ETF TrPUTOPTION · shares −41% | 0.93% | $4.68B | — | ||||||||
| AlphabetCOMMON · shares −2.1% · price +13.3% | 0.89% | $4.48B | +$526.1M | ||||||||
| AlibabaADR · shares +6.4% · price −2.1% | 0.84% | $4.21B | −$86.8M | ||||||||
| Ishares 7-10 Year Treasury BFUND · shares +103% · price +2.3% | 0.80% | $4.01B | +$44.0M | ||||||||
| AlphabetCOMMON · shares −6.9% · price +13.4% | 0.78% | $3.90B | +$461.8M | ||||||||
| MastercardCOMMON · shares −0.4% · price +4.0% | 0.75% | $3.77B | +$145.4M | ||||||||
| Chevron Corp NewCOMMON · shares +8.4% · price −3.7% | 0.75% | $3.76B | −$131.8M | ||||||||
| Bank Amer CorpCOMMON · shares −8.7% · price +3.4% | 0.72% | $3.62B | +$119.2M | ||||||||
| Jpmorgan Betabuilders CanadaFUND · shares +0.1% · price +1.2% | 0.72% | $3.61B | +$41.8M | ||||||||
| Home Depot IncCOMMON · shares +1.4% · price +12.1% | 0.70% | $3.54B | +$375.6M | ||||||||
| Jpmorgan Betabuilders Japan ETFFUND · shares +2.1% · price +4.5% | 0.69% | $3.48B | +$146.5M | ||||||||
| Coca Cola CoCOMMON · shares +1.3% · price +6.6% | 0.69% | $3.45B | +$210.1M | ||||||||
| Jpmorgan Betabuilders Europe ETFFUND · shares −13% · price −1.8% | 0.68% | $3.43B | −$62.7M | ||||||||
| Unitedhealth Group IncCOMMON · shares +8.4% · price −11.8% | 0.67% | $3.36B | −$414.5M | ||||||||
| TSMCADR · shares −5.4% · price +17.4% | 0.67% | $3.35B | +$496.3M | ||||||||
| Pfizer IncCOMMON · shares −18% · price −17.3% | 0.64% | $3.23B | −$674.3M | ||||||||
| Merck & Co IncCOMMON · shares −8.8% · price +0.4% | 0.62% | $3.11B | +$12.9M | ||||||||
| Comcast Corp NewCOMMON · shares −4.8% · price +7.3% | 0.62% | $3.10B | +$211.7M | ||||||||
| Ishares Core Msci Eafe ETFFUND · shares +1.1% · price −0.1% | 0.61% | $3.07B | −$2.0M | ||||||||
| Total · 5,794 positions | 100% | $502.15B | +$4.25B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q2 2019 to Q3 2019: 4,320 stocks held throughout, up $4.25B (+1.0%).
- Apple+$756.0M+12%
- Alphabet+$526.1M+13%
- TSMC+$496.3M+17%
- Alphabet+$461.8M+13%
- Microsoft+$439.6M+4%
- Diamondback Energy Inc−$229.3M−16%
- Unitedhealth Group Inc−$414.5M−12%
- Netflix−$642.4M−28%
- Pfizer Inc−$674.3M−17%
- Amazon−$681.9M−9%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 15 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | $1.81T+16% | SEC ↗ |
| Q1 2026 | May 13, 2026 (amended) | $1.56T−2% | SEC ↗ |
| Q4 2025 | Feb 11, 2026 | $1.59T−52% | SEC ↗ |
| Q3 2025 | Nov 7, 2025 (amended) | $3.34T+118% | SEC ↗ |
| Q2 2025 | Aug 12, 2025 | $1.53T+12% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $1.37T+2% | SEC ↗ |
| Q4 2024 | Feb 12, 2025 | $1.34T−49% | SEC ↗ |
| Q3 2024 | Nov 8, 2024 (amended) | $2.63T+8% | SEC ↗ |
| Q2 2024 | Aug 12, 2024 (amended) | $2.44T+3% | SEC ↗ |
| Q1 2024 | May 10, 2024 (amended) | $2.37T+14% | SEC ↗ |
| Q4 2023 | Feb 12, 2024 (amended) | $2.08T+130% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 | $906.36B−2% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $920.27B+12% | SEC ↗ |
| Q1 2023 | May 18, 2023 (amended) | $820.88B+8% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $758.55B+9% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $696.38B−3% | SEC ↗ |
| Q2 2022 | Aug 11, 2022 | $717.86B−14% | SEC ↗ |
| Q1 2022 | May 11, 2022 | $830.28B−4% | SEC ↗ |
| Q4 2021 | Feb 11, 2022 (amended) | $865.90B+7% | SEC ↗ |
| Q3 2021 | Nov 12, 2021 | $808.68B−4% | SEC ↗ |
| Q2 2021 | Aug 12, 2021 | $838.21B+12% | SEC ↗ |
| Q1 2021 | May 12, 2021 | $749.21B+10% | SEC ↗ |
| Q4 2020 | Feb 19, 2021 (amended) | $680.63B+14% | SEC ↗ |
| Q3 2020 | Nov 12, 2020 (amended) | $595.09B+15% | SEC ↗ |
| Q2 2020 | Aug 11, 2020 | $518.17B+22% | SEC ↗ |
| Q1 2020 | May 12, 2020 | $425.90B−21% | SEC ↗ |
| Q4 2019 | Feb 11, 2020 | $536.28B+7% | SEC ↗ |
| Q3 2019 | Nov 12, 2019 | $502.15B−2% | SEC ↗ |
| Q2 2019 | Aug 7, 2019 | $511.43B+4% | SEC ↗ |
| Q1 2019 | May 7, 2019 | $489.55B+13% | SEC ↗ |
| Q4 2018 | Feb 11, 2019 | $432.49B−17% | SEC ↗ |
| Q3 2018 | Nov 13, 2018 (amended) | $522.20B+7% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $486.35B+4% | SEC ↗ |
| Q1 2018 | May 10, 2018 | $466.55B−2% | SEC ↗ |
| Q4 2017 | Feb 13, 2018 | $474.64B+5% | SEC ↗ |
| Q3 2017 | Nov 9, 2017 | $453.26B+4% | SEC ↗ |
| Q2 2017 | Aug 9, 2017 | $437.53B−0% | SEC ↗ |
| Q1 2017 | May 10, 2017 | $437.58B+5% | SEC ↗ |
| Q4 2016 | Feb 6, 2017 | $416.17B+2% | SEC ↗ |
| Q3 2016 | Nov 4, 2016 | $406.33B+1% | SEC ↗ |
| Q2 2016 | Aug 8, 2016 | $401.04B+3% | SEC ↗ |
| Q1 2016 | May 10, 2016 | $390.67B | SEC ↗ |